Search Tag: intensive care
2021 22 Dec
Sedana Medical AB (publ) has announces that the company has submitted an application for market approval for Sedaconda (isoflurane) for inhaled sedation in intensive care in Italy. “With the application in Italy, we are hoping to bring our Sedaconda products to yet another important European market. Having received market approval in 14 European...Read more
2021 23 Nov
CAR-T therapy is a promising treatment for B-cell malignancies but is also associated with toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Frequent monitoring, timely recognition and prompt management in ICU are paramount to ensure good outcomes. Introduction...Read more
2021 23 Nov
Recommendations for the management of nutrition of COVID-19 patients provide guidelines for nutrition risk screening, requirements, timing, route and mode of feeding, monitoring, equipment and workforce requirements. The worldwide pandemic of COVID-19 continues to impact all aspects of intensive care unit (ICU) management, including nutritional...Read more
2021 30 Nov
Moderator Jean-Louis Vincent Editor-in-Chief ICU Management & Practice Professor Department of Intensive Care Erasme Hospital Université libre de Bruxelles Brussels, Belgium [email protected] Panellists Topic: Reversal of Direct Oral Anticoagulants Charles Marc Samama Professor of Anaesthesiology Editor-in-Chief, European Journal...Read more
2021 05 Oct
ESICM President Maurizio Cecconi, President-Elect Elie Azoulay and Congress Chair Armand Girbes officially opened the LIVES Digital 2021 Congress with a welcome address, an update on ESICM’s activities and initiatives and an overview of the Congress programme. The COVID-19 crisis has put intensive care medicine at the heart of all concerns within...Read more
2021 21 Sep
Over the last fifty years, haemodynamic monitoring techniques have progressed quite significantly, moving from bulky sphygmographs to invasive catheters to noninvasive digital monitors that provide continuous values of multiple haemodynamic variables. Haemodynamic monitoring concepts have also changed and have progressed from global macrohaemodynamic...Read more
2021 14 Sep
More than forty randomised trials have evaluated early mobilisation and rehabilitation in ICUs in the last decade. These trials usually aim to reduce the incidence of ICU acquired weakness (ICUAW) which is known to be associated with poor long-term survival, poor physical function and decreased quality of life. Eight international guidelines recommend...Read more
2021 30 Aug
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company will host a symposium at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels on August 31-September 3, 2021, where the full details on the Sedaconda study will be presented. In addition, further data on inhaled sedation in COVID-19...Read more
2021 24 Aug
Change content default valueSex interplays with the development of several diseases and syndromes, impacting differently the need for intensive care unit admission between men and women. All in all, men are more prone to develop critical illness than women, which explains their over-representation in the intensive care unit. On the other hand, treatments...Read more
2021 13 Aug
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has received market approval for inhaled sedation in France. The approval applies to the drug Sedaconda (isoflurane)* for administration via the medical device AnaConDa (undergoing name change to Sedaconda ACD) for inhaled sedation in intensive care in France....Read more
2021 22 Jun
Sedana Medical AB (publ) today announced that the company's pivotal phase III study Sedaconda (SED001) has been named one of the three best posters at the 52nd intensive care conference DGIIN & ÖGIAIN 16–18 June 2021. "It is very positive that the Sedaconda study is receiving this attention in Germany, which is our largest market. The strong study...Read more
2021 19 Apr
An overview of the potential of POCUS on clinical decision making at the bedside and the need to add it as a new diagnostic tool by intensive care physiotherapists. Introduction Intensive care physiotherapists often rely on standard assessment tools, such as measures of physiological function (arterial blood gases), adequacy/quality...Read more
2020 10 Nov
An ever-expanding array of applications have been developed for ultrasound, including its goal-directed use at the bedside, often called point-of-care ultrasound (POCUS). In Australia, New Zealand, the United Kingdom, and many other European and Asian countries, neonatologist-performed, targeted POCUS is now a routine practice in neonatal intensive...Read more
